摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

JP4-039 | 1205492-16-5

中文名称
——
中文别名
——
英文名称
JP4-039
英文别名
——
JP4-039化学式
CAS
1205492-16-5
化学式
C23H42N3O4
mdl
——
分子量
424.604
InChiKey
AJHRJWQXDNEJAG-SXSDINLZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    30
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    71.7
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    JP4-039L-arabo-ascorbic acid 作用下, 以 甲醇 为溶剂, 反应 0.35h, 生成
    参考文献:
    名称:
    An Uncharged Oxetanyl Sulfoxide as a Covalent Modifier for Improving Aqueous Solubility
    摘要:
    Low aqueous solubility is a common challenge in drug discovery and development and can lead to inconclusive biological assay results. Attaching small, polar groups that do not interfere with the bioactivity of the pharmacophore often improves solubility, but there is a dearth of viable neutral moieties available for this purpose. We have modified several poorly soluble drugs or drug candidates with the oxetanyl sulfoxide moiety of the DMSO analog MMS-350 and noted in most cases a moderate to large improvement of aqueous solubility. Furthermore, the membrane permeability of a test sample was enhanced compared to the parent compound.
    DOI:
    10.1021/ml5001504
  • 作为产物:
    描述:
    参考文献:
    名称:
    Large-Scale Asymmetric Synthesis of the Bioprotective Agent JP4-039 and Analogs
    摘要:
    JP4-039 is a novel nitroxide conjugate capable of crossing lipid bilayer membranes and scavenging reactive oxygen species (ROS). An efficient and scalable one-pot hydrozirconation-transmetalation-imine addition methodology has been developed for its asymmetric preparation. Furthermore, this versatile methodology allows for the synthesis of cyclopropyl and fluorinated analogs of the parent lead structure.
    DOI:
    10.1021/ol200567p
点击查看最新优质反应信息

文献信息

  • TARGETED NITROXIDE AGENTS
    申请人:Wipf Peter
    公开号:US20100035869A1
    公开(公告)日:2010-02-11
    Provided herein are compositions and related methods useful for free radical scavenging, with particular selectivity for mitochondria. The compounds comprise a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity. Also provided herein are methods, for preventing, mitigating and treating damage caused by radiation. The method comprises delivering a compound, as described herein, to a patient in an amount and dosage regimen effective to prevent, mitigate or treat damage caused by radiation.
    本文提供了一种对自由基清除有用的组合物和相关方法,具有特定选择性作用于线粒体。这些化合物包括一个连接到线粒体靶向基团的亚硝基含有基团。这些化合物可以交联成二聚体而不丧失活性。本文还提供了一种用于预防、缓解和治疗辐射引起的损伤的方法。该方法包括向患者输送一种如本文所述的化合物,以有效地预防、缓解或治疗辐射引起的损伤。
  • INTRAESOPHAGEAL ADMINISTRATION OF TARGETED NITROXIDE AGENTS FOR PROTECTION AGAINST IONIZING IRRADIATION-INDUCED ESOPHAGITIS
    申请人:University of Pittsburgh - Of the Commonwealth System of Higher Education
    公开号:US20190210969A1
    公开(公告)日:2019-07-11
    Provided herein are compositions and related methods useful for prevention or mitigation of ionizing radiation-induced esophagitis. The compositions comprise compounds comprising a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity. The method comprises delivering a compound, as described herein, to a patient in an amount and dosage regimen effective to prevent or mitigate esophageal damage caused by radiation.
    本文提供了一种用于预防或缓解电离辐射诱导的食管炎的组合物和相关方法。这些组合物包括含有与线粒体靶向基团相连的亚硝基含有基团的化合物。这些化合物可以交联成二聚体而不丧失活性。该方法包括向患者输送本文所述的化合物,以有效预防或缓解由辐射引起的食道损伤。
  • A two-step synthesis of the bioprotective agent JP4-039 from N-Boc-l-leucinal
    作者:Barbara Bernardim、Antonio C.B. Burtoloso
    DOI:10.1016/j.tet.2013.10.059
    日期:2014.5
    An expedited synthesis of the bioprotective agent JP4-039 is described from N-Boc-l-leucinal in 50% overall yield. The synthesis involves the use of an α,β-unsaturated diazoketone as the key intermediate, followed by a photochemical Wolff rearrangement in the presence of 4-amino-TEMPO (4-AT).
    从N- Boc- 1-亮氨酸描述了生物保护剂JP4-039的快速合成,总产率为50%。合成过程涉及使用α,β-不饱和重氮酮作为关键中间体,然后在4-氨基-TEMPO(4-AT)存在下进行光化学Wolff重排。
  • Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondria
    作者:Marie-Céline Frantz、Erin M. Skoda、Joshua R. Sacher、Michael W. Epperly、Julie P. Goff、Joel S. Greenberger、Peter Wipf
    DOI:10.1039/c3ob40489g
    日期:——
    JP4-039 is a lead structure in a series of nitroxide conjugates that are capable of accumulating in mitochondria and scavenging reactive oxygen species (ROS). To explore structure–activity relationships (SAR), new analogs with variable nitroxide moieties were prepared. Furthermore, fluorophore-tagged analogs were synthesized and provided the opportunity for visualization in mitochondria. All analogs were tested for radioprotective and radiomitigative effects in 32Dcl3 cells.
    JP4-039 是一系列硝基氧化物共轭物的先导结构,能够在线粒体中积累并清除活性氧(ROS)。为了探索结构-活性关系(SAR),我们制备了具有可变亚硝基的新类似物。此外,还合成了荧光团标记的类似物,为线粒体中的可视化提供了机会。所有类似物都在 32Dcl3 细胞中进行了辐射防护和辐射诱变效应测试。
  • [EN] BIFUNCTIONAL COMPOUNDS<br/>[FR] COMPOSÉS BIFONCTIONNELS
    申请人:UNIV PITTSBURGH
    公开号:WO2013059651A1
    公开(公告)日:2013-04-25
    A compound having the formula (I) wherein X is S, SO or SO2; one of R1, R2, and R3 is O and the others of R1, R2 and R3 are independently, the same or different, CH2, or CR13 wherein, R13 is an alkyl group, an alkenyl group, an alkynyl group, a trialkylsilyl group, or -(CH2)mOR15, wherein R15 is an alkyl group or an aryl group and m is an integer in the range of 1 to 10, and one of R5, R6, and R7 is O and the others of R5, R6 and R7 are independently, the same or different, CH2, or CR14 wherein, R14 is an alkyl group, an alkenyl group, an alkynyl group, a trialkylsilyl group, or -(CH2)nOR16, wherein R16 is an alkyl group or an aryl group and n is an integer in the range of 1 to 10; R4 and R8 are independently, the same or different, H, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, a C1-C3 alkoxy group, an aryloxy group, or -(CH2)qOR17, wherein R17 is an alkyl group or an aryl group and q is an integer in the range of 1 to 10, provided that R4 is not a C1-C3 alkoxy group or an aryloxy group when R1 or R3 is O and R8 is not a C1-C3 alkoxy group or an aryloxy group when R5 or R7 is O; R9, R10, R11 and R12 are independently, the same or different, H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group.
    化合物的化学式为(I),其中X为S、SO或SO2;R1、R2和R3中的一个为O,而R1、R2和R3中的其他基团独立地相同或不同,为CH2或CR13,其中R13为烷基、烯基、炔基、三烷基硅基或-(CH2)mOR15,其中R15为烷基或芳基,m为1到10的整数;R5、R6和R7中的一个为O,而R5、R6和R7中的其他基团独立地相同或不同,为CH2或CR14,其中R14为烷基、烯基、炔基、三烷基硅基或-(CH2)nOR16,其中R16为烷基或芳基,n为1到10的整数;R4和R8独立地相同或不同,为H、烷基、烯基、炔基、芳基、杂芳基、C1-C3烷氧基、芳氧基或-(CH2)qOR17,其中R17为烷基或芳基,q为1到10的整数,但当R1或R3为O时,R4不为C1-C3烷氧基或芳氧基,当R5或R7为O时,R8不为C1-C3烷氧基或芳氧基;R9、R10、R11和R12独立地相同或不同,为H、烷基、烯基、炔基或芳基。
查看更多